ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1858

Standardized Mortality Ratios for Cause-Specific Deaths in Lupus Patients Followed Prospectively at a Single Centre Lupus Clinic

Barry J. Sheane1, Dominique Ibanez2, Dafna D. Gladman3 and Murray B. Urowitz3, 1Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: infection and morbidity and mortality, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Complications of Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose

Despite the significant improvement in survival rates of patients with systemic lupus erythematosus (SLE) over the last four decades, mortality rates have remained at least 3 times that of the general population. We have recently reported from our longitudinal cohort study that infection is responsible for almost half of all deaths in lupus within the first 5 years of disease, and for over a third of deaths overall.

The aim of this study was to examine the standardized mortality ratios (SMR) for all-cause and cause-specific deaths in SLE patients followed prospectively at a large lupus clinic between 1970 and 2012.

Methods

Primary causes of death were recorded and acquired from autopsy reports, discharge summaries, hospital notes, and death certificates and divided into 5 categories: active lupus, atherosclerosis-related, infection, malignancy and ‘other’, all as determined by the certifying clinician.  For determination of the SMRs, cause-of-death data for the general population (by age, sex and year) were extracted from official records of the relevant provincial registry. SMRs were calculated as the ratio of observed deaths in the SLE cohort to the age, sex and year-match in the general population for all-cause and causes due to infection, atherosclerosis and malignancy.

SMRs were modelled using Poisson regression with the log of the expected number of events as an offset, and adjusted for age, sex, disease duration and decade of death.

Results

Of 259 patients known to have died, causes of death were established in 198 cases. Mean disease duration to time of death was 15.0 ± 11.3 years. Sixty-eight deaths were attributable to infection, 44 to atherosclerosis, 23 to malignancy and 39 due to active lupus.

For deaths due to all causes, the SMR falls significantly for the succeeding decade, from 12.02 (CI 7.67 – 18.82) for a female with < 5 years of SLE in the 1970s to 5.08 (CI 2.18 – 11.87) in the 2000s (p < 0.0001), with a similar decrease in those with SLE > 5 years.

For infection, there is a significant decade-on-decade reduction in the SMR, from 188 (CI 86 – 409) in the 1970s, to 117 (CI 42 – 324) in the 1980s, 73 (CI 21 – 256) in the 1990s and 46 (CI 10 – 203) in the 2000s (p < 0.0001), regardless of disease duration.

The SMRs for atherosclerosis and malignancy have also decreased over the 4 decades, from 14.09 (CI 9.99 – 16.86) and 1.79 (CI 1.12 – 2.87) in the 1970s, respectively, to 6.43 (CI 1.63 – 13.16) and 1.3 (CI 0.2 – 8.57) (p > 0.05).

Conclusion

Infection is the dominant cause of death in SLE, despite significant decreases in SMR over the last 40 years. Its prevalence as a cause-of-death is 40 times that of the general population. While primary prevention of cardiovascular disease should continue to be targeted in SLE, improvement in strategies to prevent and adequately treat infection in SLE require prioritisation.


Disclosure:

B. J. Sheane,
None;

D. Ibanez,
None;

D. D. Gladman,
None;

M. B. Urowitz,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/standardized-mortality-ratios-for-cause-specific-deaths-in-lupus-patients-followed-prospectively-at-a-single-centre-lupus-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology